Hypofractionated intensity modulated radiotherapy

RADIATION2 trials

Sponsors

M.D. Anderson Cancer Center, University of Texas Southwestern Medical Center

Conditions

Human Papillomavirus-Related CarcinomaOropharyngeal CancerProstate Cancer

Phase 1

HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer

CompletedNCT04580446

University of Texas Southwestern Medical CenterHuman Papillomavirus-Related Carcinoma, Oropharyngeal Cancer

Start: 2020-12-03End: 2024-12-20Updated: 2025-12-15

Phase 3

A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation

M.D. Anderson Cancer CenterProstate Cancer

Start: 2001-01-03End: 2021-10-31Updated: 2021-01-25